Lung cancer and Toll-like receptors Aldo PintoSilvana MorelloRosalinda Sorrentino Review 26 July 2011 Pages: 1211 - 1220
Therapeutic effects of metformin in breast cancer: involvement of the immune system? Sarah SchottAngelika BierhausChristoph Domschke Opinion Paper 17 June 2011 Pages: 1221 - 1225
Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses Sofia R. GameiroJorge A. CaballeroJames W. Hodge Original article 05 May 2011 Pages: 1227 - 1242
Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2′-Deoxycytidine Mengyong YanNourredine HimoudiJohn Anderson original article 07 May 2011 Pages: 1243 - 1255
Immunotherapy eradicates metastases with reversible defects in MHC class I expression Cristina GarridoIrene RomeroFederico Garrido Original article 08 May 2011 Pages: 1257 - 1268
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancy Bethany L. Mundy-BosseGregory S. YoungGregory B. Lesinski Original article 21 May 2011 Pages: 1269 - 1279
Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4+ and CD8+ T cells Kristan D. GuenterbergGregory B. LesinskiWilliam E. Carson III Original article 21 May 2011 Pages: 1281 - 1288
Gemcitabine enhances Wilms’ tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response Akitaka TakaharaShigeo KoidoSadamu Homma Original article 24 May 2011 Pages: 1289 - 1297
MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing Lei BaoKimberly DunhamKenneth Lucas Original article 28 May 2011 Pages: 1299 - 1307
Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN S. M. GearyC. D. LemkeA. K. Salem Original article 28 May 2011 Pages: 1309 - 1317
CTL recognition of a novel HLA-A*0201-binding peptide derived from glioblastoma multiforme tumor cells Cheryl E. MyersPaul HanavanDouglas F. Lake Original article 29 May 2011 Pages: 1319 - 1332
A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4+ and CD8+ T-cell as well as B-cell responses Frank NeumannBoris KubuschokMichael Pfreundschuh Original article 01 June 2011 Pages: 1333 - 1346
Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model David M. FoureauIain H. McKillopJonathan C. Salo Original Article 03 June 2011 Pages: 1347 - 1356
Obituary: Joseph Lustgarten, 1963–2011 Suzanne Ostrand-RosenbergEsteban CelisLinda Sherman Short communication 17 August 2011 Pages: 1357 - 1358
